 | Lilly's CYRAMZA® (ramucirumab) Receives FDA Approval as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
www.prnewswire.com - May 29 at 9:39 PM |
 | Lilly Cleared by FDA to Market Alzheimer's Detection Drug
finance.yahoo.com - May 29 at 2:35 PM |
| FDA Okays Lilly's Alzheimer's Disease Diagnostic Agent Tauvid
finance.yahoo.com - May 29 at 2:35 PM |
 | Diabetes Care Drugs Market Precise Outlook 2024- Novo Nordisk, Sanofi, Eli Lilly, Takeda, Pfizer, Janssen Pharmaceuticals, Astellas
www.marketwatch.com - May 29 at 9:35 AM |
| Lilly gets FDA approval for Alzheimer's diagnostic agent
finance.yahoo.com - May 29 at 9:35 AM |
| Veeva Systems (VEEV) Q1 Earnings and Revenues Beat Estimates
finance.yahoo.com - May 29 at 9:35 AM |
 | U.S. FDA approves Eli Lilly's diagnostic agent for Alzheimer's disease
www.reuters.com - May 28 at 10:22 PM |
| Eli Lilly Earns Landmark Approval for Alzheimer's Disease Imaging Agent
finance.yahoo.com - May 28 at 10:22 PM |
| 3 Investing Facts About Required Minimum Distributions You Need to Know - May 28, 2020
finance.yahoo.com - May 28 at 12:22 PM |
| Insulin Market Report 2020: Includes Revenue Data (2013-2022) for Novo Nordisk, Sanofi Aventis, Eli Lilly, Merck & Co, and Beckton Dickinson
www.prnewswire.com - May 27 at 3:19 PM |
|
| White House announces plan for Medicare enrollees to get insulin for $35 a month
finance.yahoo.com - May 27 at 9:46 AM |
 | Eli Lilly Shares Cross 2% Yield Mark
www.nasdaq.com - May 26 at 6:23 PM |
| CanSino Biologics' Covid-19 Vaccine Shows Early Promise
finance.yahoo.com - May 26 at 6:23 PM |
| Statement from Lilly Chairman and CEO Dave Ricks on New Part D Senior Savings Model
finance.yahoo.com - May 26 at 6:23 PM |
 | Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining empagliflozin’s effects following an acute myocardial ...
www.businesswire.com - May 26 at 1:21 PM |
| BRIEF-Boehringer Ingelheim and Lilly To Collaborate With Duke Clinical Research Institute On A Pragmatic Trial
www.reuters.com - May 26 at 1:21 PM |
| Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences’ COVID-19 Neutralizing Antibodies
finance.yahoo.com - May 26 at 1:21 PM |
| Lilly, Junshi Biosciences plan to start human trials of COVID-19 antibody in Q2
finance.yahoo.com - May 26 at 1:21 PM |
| Eli Lilly, Junshi Biosciences To Start Human Testing Of Covid-19 Antibodies By Q2
finance.yahoo.com - May 26 at 1:21 PM |
| Emgality® Shows Improvement in Work Productivity and Health and Well-Being Between Attacks in Patients with Migraine and a History of Preventive Treatment Failure
finance.yahoo.com - May 26 at 8:20 AM |
| Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining Jardiance's® effects following an acute myocardial infarction
finance.yahoo.com - May 26 at 8:20 AM |
| Antidiabetics Market 2015 In Deep Analysis, Expert Reviews and Healthcare Outlook 2027; Merck & Co. Inc, Shenzhen Kexing, Sanofi-Aventis
www.marketwatch.com - May 25 at 1:48 PM |
| Peptide Therapeutics Market Expected to Grow at CAGR of 8.2% by 2023|Pfizer Inc., Novo Nordisk, Eli Lilly and Company
www.marketwatch.com - May 25 at 1:48 PM |
| Why Is Lilly (LLY) Down 5.5% Since Last Earnings Report?
finance.yahoo.com - May 23 at 5:07 PM |
 | Short Interest in Eli Lilly And Co (NYSE:LLY) Drops By 9.5%
www.americanbankingnews.com - May 22 at 12:14 AM |
 | How Eli Lilly’s Investors Cashed In 90% Capital Gains While Sales Barely Moved?
www.forbes.com - May 21 at 12:34 PM |
|
| CanSino’s 23% Stock Slump Shows Perils of Chasing Vaccine Hype
finance.yahoo.com - May 21 at 12:34 PM |
| Is Eli Lilly and (LLY) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - May 21 at 12:34 PM |
| Animal Antibiotics and Antimicrobials Market to See Huge Growth by 2025 | Eli Lilly and Company , Bayer AG, Virbac
www.marketwatch.com - May 21 at 7:33 AM |
| Does Eli Lilly (NYSE:LLY) Deserve A Spot On Your Watchlist?
finance.yahoo.com - May 21 at 7:33 AM |
| BRIEF-Eli Lilly - Study Results Demonstrate Societal Cost Burden During Early Stages Of Alzheimer's Disease
www.reuters.com - May 21 at 2:05 AM |
| Eli Lilly Reports Results Of GERAS-US Study - Quick Facts
www.nasdaq.com - May 19 at 2:17 PM |
| AstraZeneca's Enhertu Gets Breakthrough Therapy Tag for NSCLC
finance.yahoo.com - May 19 at 2:17 PM |
| Results of GERAS-US Study Demonstrate Societal Cost Burden for Patients and Caregivers During Early Stages of Alzheimer's Disease
finance.yahoo.com - May 19 at 9:16 AM |
| 3 Market-Beating Dividend Stocks to Buy Today
finance.yahoo.com - May 18 at 2:52 PM |
| Biotechs harness AI in battle against Covid-19
finance.yahoo.com - May 15 at 12:06 AM |
| TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
finance.yahoo.com - May 13 at 11:03 PM |
| Drug Sector Highly Resilient Amid Coronavirus Mayhem: 5 Picks
finance.yahoo.com - May 13 at 1:01 PM |
| HMS Holdings (HMSY) Earnings and Revenues Beat Estimates in Q1
finance.yahoo.com - May 13 at 1:01 PM |
| Phibro (PAHC) Q3 Earnings Surpass Estimates, Margin Declines
finance.yahoo.com - May 13 at 1:01 PM |
| Global Vascular Endothelial Growth Factor B Market Assessing Major Growth Opportunities | Alteogen Inc, CSL Ltd, Eli Lilly and Company
www.marketwatch.com - May 13 at 1:30 AM |
| National Vision (EYE) Q1 Earnings Top Estimates, Margin Falls
finance.yahoo.com - May 12 at 3:29 PM |
| Allscripts (MDRX) Q1 Earnings and Revenues Miss Estimates
finance.yahoo.com - May 12 at 3:29 PM |
| China's Junshi Bio, Lilly to Co-Develop Covid-19 Antibody Therapies
finance.yahoo.com - May 12 at 3:47 AM |
| Cluster Headache Syndrome Drug Market 2020 Analysis and Precise Outlook: Center Laboratories Inc, Eli Lilly and Company, Novartis AG
www.marketwatch.com - May 11 at 10:47 PM |
| Metabotropic Glutamate Receptor 2 Market 2020-2027: Eli Lilly and Company,Johnson & Johnson, Merck & Co Inc
www.marketwatch.com - May 11 at 10:47 PM |
 | Eli Lilly's Retevmo, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - May 11 at 5:47 PM |
 | Eli Lilly, with big expansion plans in Durham, buys 110 acres
www.bizjournals.com - May 11 at 5:47 PM |
| A Triangle Formation on Drug Maker Eli Lilly Is Ready for an Upside Breakout
finance.yahoo.com - May 11 at 5:47 PM |
| LLY Stock Approaching Support: Here Are Two Option Trade Ideas
finance.yahoo.com - May 11 at 5:47 PM |
